Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma

Cholangiocarcinomas (CCAs) are subdivided into intrahepatic cholangiocarcinoma (iCCA) and extrahepatic cholangiocarcinoma (eCCA) (further divided into perihilar (pCCA) and distal (dCCA)) based on their location.

Source: Cancer Treatment Reviews - September 15, 2023 Category: Cancer & Oncology Authors: Angela Lamarca, Lorena Ostios, Mair éad G McNamara, Carlos Garzon, Jack P Gleeson, Julien Edeline, Ana Herrero, Richard A Hubner, Victor Moreno, Juan W Valle Tags: Anti-tumour Treatment Source Type: research